Patient demographics at baseline (all analysis sets)
| Overall (exposed set) | Effectiveness analysis set | First-year completers’ set | Second-year completers’ set | |
|---|---|---|---|---|
| N | 2609 | 2227 | 1695 | 1184 |
| Age at diagnosis, years (mean±SD) | 76.8±8.4 | 76.8±8.2 | 76.7±8.0 | 76.8±7.8 |
| Age at treatment start, years (mean±SD) | 76.9±8.4 | 76.9±8.2 | 76.9±7.9 | 77.0±7.8 |
| Women, n (%) | 1593 (61.1) | 1349 (60.6) | 1051 (62.0) | 737 (62.2) |
| Insurance*, n (%) | ||||
| Public | 2214 (84.9) | 1917 (86.1) | 1472 (86.8) | 1020 (86.1) |
| Private | 183 (7.0) | 162 (7.3) | 102 (6.0) | 64 (5.4) |
| None | 186 (7.1) | 126 (5.7) | 109 (6.4) | 86 (7.3) |
| Other | 6 (0.2) | 4 (0.2) | 0 | 0 |
| Missing | 29 (1.1) | 26 (1.2) | 20 (1.2) | 17 (1.4) |
| Angiographic findings | n=1951 | n=1708 | n=1308 | n=914 |
| No CNV | 47 (2.4) | 44 (2.6) | 31 (2.4) | 20 (2.2) |
| Classic CNV | 550 (28.2) | 473 (27.7) | 344 (26.3) | 219 (24.0) |
| Classic and occult | 226 (11.6) | 199 (11.7) | 140 (10.7) | 90 (9.8) |
| Occult | 762 (39.1) | 694 (40.6) | 546 (41.7) | 377 (41.2) |
| Disciform scar | 11 (0.6) | 9 (0.5) | 4 (0.3) | 2 (0.2) |
| Unknown | 340 (17.4) | 274 (16.0) | 231 (17.7) | 196 (21.4) |
| Missing | 15 (0.8) | 15 (0.9) | 12 (0.9) | 10 (1.1) |
| Visual acuity, letters (mean±SD) | NA | n=2147 55.4±18.4 | n=1642 56.9±17.8 | n=1146 57.2±17.9 |
*Multiple responses possible.
CNV, choroidal neovascularisation; NA, not available.